126 related articles for article (PubMed ID: 30679392)
21. Burden of HPV-caused cancers in Denmark and the potential effect of HPV-vaccination.
Skorstengaard M; Thamsborg LH; Lynge E
Vaccine; 2017 Oct; 35(43):5939-5945. PubMed ID: 28923423
[TBL] [Abstract][Full Text] [Related]
22. The epidemiology behind the HPV vaccine discovery.
Koutsky L
Ann Epidemiol; 2009 Apr; 19(4):239-44. PubMed ID: 19344861
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of type-specific oncogenic human papillomavirus infection assessed by HPV E6/E7 mRNA among women with high-grade cervical lesions.
Wang HY; Park S; Lee D; Kim S; Kim G; Park KH; Lee H
Int J Infect Dis; 2015 Aug; 37():135-42. PubMed ID: 26141414
[TBL] [Abstract][Full Text] [Related]
24. Variation in genital human papillomavirus infection prevalence and vaccination coverage among men and women in the USA.
Han JJ; Tarney CM; Song J
Future Oncol; 2017 Jun; 13(13):1129-1132. PubMed ID: 28589730
[TBL] [Abstract][Full Text] [Related]
25. Cost analysis of Human Papillomavirus-related cervical diseases and genital warts in Swaziland.
Ginindza TG; Sartorius B; Dlamini X; Östensson E
PLoS One; 2017; 12(5):e0177762. PubMed ID: 28531205
[TBL] [Abstract][Full Text] [Related]
26. Prevention of human papillomavirus infections and associated diseases by vaccination: a new hope for global public health.
Harper DM
Public Health Genomics; 2009; 12(5-6):319-30. PubMed ID: 19684444
[TBL] [Abstract][Full Text] [Related]
27. Genotypic prevalence of human papillomavirus infection during normal pregnancy: a cross-sectional study.
Kim YH; Park JS; Norwitz ER; Park JW; Kim SM; Lee SM; Park CW; Kim BJ; Koo JN; Oh IH; Song YS
J Obstet Gynaecol Res; 2014 Jan; 40(1):200-7. PubMed ID: 23815316
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of anal human papillomavirus infection and anal HPV-related disorders in women: a systematic review.
Stier EA; Sebring MC; Mendez AE; Ba FS; Trimble DD; Chiao EY
Am J Obstet Gynecol; 2015 Sep; 213(3):278-309. PubMed ID: 25797230
[TBL] [Abstract][Full Text] [Related]
29. Epidemiology and burden of HPV-related disease.
Serrano B; Brotons M; Bosch FX; Bruni L
Best Pract Res Clin Obstet Gynaecol; 2018 Feb; 47():14-26. PubMed ID: 29037457
[TBL] [Abstract][Full Text] [Related]
30. Assessing genital human papillomavirus genoprevalence in young Australian women following the introduction of a national vaccination program.
Osborne SL; Tabrizi SN; Brotherton JM; Cornall AM; Wark JD; Wrede CD; Jayasinghe Y; Gertig DM; Pitts MK; Garland SM;
Vaccine; 2015 Jan; 33(1):201-8. PubMed ID: 25444787
[TBL] [Abstract][Full Text] [Related]
31. Monitoring vaccine and non-vaccine HPV type prevalence in the post-vaccination era in women living in the Basilicata region, Italy.
Carozzi F; Puliti D; Ocello C; Anastasio PS; Moliterni EA; Perinetti E; Serradell L; Burroni E; Confortini M; Mantellini P; Zappa M; Dominiak-Felden G
BMC Infect Dis; 2018 Jan; 18(1):38. PubMed ID: 29334901
[TBL] [Abstract][Full Text] [Related]
32. Mathematical models for predicting the epidemiologic and economic impact of vaccination against human papillomavirus infection and disease.
Dasbach EJ; Elbasha EH; Insinga RP
Epidemiol Rev; 2006; 28():88-100. PubMed ID: 16740585
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV vaccines.
Monsonego J; Zerat L; Syrjänen K; Zerat JC; Smith JS; Halfon P
Vaccine; 2012 Jul; 30(35):5215-21. PubMed ID: 22713720
[TBL] [Abstract][Full Text] [Related]
34. Getting to know human papillomavirus (HPV) and the HPV vaccines.
Smith GD; Travis L
J Am Osteopath Assoc; 2011 Mar; 111(3 Suppl 2):S29-34. PubMed ID: 21415377
[TBL] [Abstract][Full Text] [Related]
35. Strategies against human papillomavirus infection and cervical cancer.
Jung WW; Chun T; Sul D; Hwang KW; Kang HS; Lee DJ; Han IK
J Microbiol; 2004 Dec; 42(4):255-66. PubMed ID: 15650698
[TBL] [Abstract][Full Text] [Related]
36. TPrevalence of HPV in Adults Aged 18-69: United States, 2011-2014.
McQuillan G; Kruszon-Moran D; Markowitz LE; Unger ER; Paulose-Ram R
NCHS Data Brief; 2017 Apr; (280):1-8. PubMed ID: 28437239
[TBL] [Abstract][Full Text] [Related]
37. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
Markowitz LE; Dunne EF; Saraiya M; Lawson HW; Chesson H; Unger ER; ;
MMWR Recomm Rep; 2007 Mar; 56(RR-2):1-24. PubMed ID: 17380109
[TBL] [Abstract][Full Text] [Related]
38. Economic burden of human papillomavirus-related diseases in Italy.
Baio G; Capone A; Marcellusi A; Mennini FS; Favato G
PLoS One; 2012; 7(11):e49699. PubMed ID: 23185412
[TBL] [Abstract][Full Text] [Related]
39. Human Papillomavirus Genotype Distribution Among 18,815 Women in 13 Korean Cities and Relationship With Cervical Cytology Findings.
Nah EH; Cho S; Kim S; Cho HI
Ann Lab Med; 2017 Sep; 37(5):426-433. PubMed ID: 28643492
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of human papillomavirus in anal and oral sites among patients with genital warts.
Kofoed K; Sand C; Forslund O; Madsen K
Acta Derm Venereol; 2014 Mar; 94(2):207-11. PubMed ID: 24096893
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
